Hepatitis/MASH

Approximately 2.3 million people worldwide are infected with both HIV and hepatitis C virus.

Merck has applauded the US Department of Veterans Affairs for broadening access to treatment for Veterans with chronic hepatitis C virus infection.

Major breakthroughs in hepatitis C virus research hold promise for patient care and control of viral global health crises.

Zepatier can be used with or without ribavirin and does not require interferon.

Research addresses whether the prior authorization process creates a barrier to timely and effective care for hepatitis C.

Nearly 1 of 4 initial requests for Harvoni were denied in a recent study of hepatitis C drug coverage.

Zepatier is approved for the treatment of patients with chronic hepatitis C virus genotypes 1 and 4.

Viekirax and Exviera combination showed promising results in the treatment of patients with chronic HCV genotype 1b with compensated cirrhosis.

Researchers compare side effects for top selling hep C medications Zepatier, Sovaldi, Harvoni, and Viekira Pak.

Researchers compare top selling hep C medications Zepatier, Sovaldi, Harvoni, and Viekira Pak.

Military veteran tried to manage the symptoms of hepatitis C treatment before Harvoni cured him of the disease.

Research explores treatment of drug users with hepatitis C virus (HCV) infection with direct-acting antivirals.

Discovery holds promise for treatment of cirrhosis and liver damage related to hepatitis C.

The FDA has approved Gilead Sciences' supplemental new drug applications for ledipasvir/sofosbuvir (Harvoni), which can treat chronic hepatitis C patients with advanced liver disease.

New option approved for liver transplant patients and individuals with decompensated cirrhosis.

New option approved for liver transplant patients and individuals with decompensated cirrhosis.

Consuming less dietary cholesterol may reduce mortality or transplantation in women with hepatitis C.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the implications of rising drug costs on specialty pharmacy.

Most new cases of hepatitis C infection in New York City found in the baby boomer generation.

HCV transmission model predicts significant long term effect of direct-acting antivirals.

Zepatier is priced considerably lower with similar efficacy to Harvoni and Sovaldi.

Prohibitive cost to Medicaid for hepatitis C medications and high prices of generic and off-patent drugs evaluated.

Zepatier is priced considerably lower with similar efficacy to Harvoni and Sovaldi.

Coffee appears to confer a number of protective effects against liver disease.